Skip to main content
ConductScienceScienceDex
NIH funding notice RFA-OD-20-021

Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (Fast-Track STTR Clinical Trial Not Allowed)

Closed on September 18, 2020.

Posted
August 6, 2020
Close date
September 18, 2020
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $510,026 in first-year total cost, median $255,013.

Most frequent study sections

  1. ZDE1-SRC(99)2

Most frequent institutions

  1. AEROSOL DEVICES, INC.1
  2. INNOTECH PRECISION MEDICINE, INC1
Competing awards under RFA-OD-20-021 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2021A multimodal platform for Oral screening of COVID-191R42DE030829-01KHOSRAVI-FAR, ROYAINNOTECH PRECISION MEDICINE, INC, MA$255,999ZDE1
2021A SARS-CoV-2 Breathalyzer for Direct Virus Detection1R42DE030832-01KEADY, PATRICIA BEAAEROSOL DEVICES, INC., CO$254,027ZDE1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

Start your CVHow the NIH biosketch works
RFA-OD-20-021: Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (Fast-Track STTR Clinical Trial Not Allowed) | ScienceDex | ConductScience